HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $86,251 | -21.9% | 963 | -25.8% | 0.00% | – |
| Q2 2023 | $110,460 | +6.9% | 1,297 | +4.2% | 0.00% | – |
| Q1 2023 | $103,309 | +11.1% | 1,245 | +5.7% | 0.00% | – |
| Q4 2022 | $93,000 | +12.0% | 1,178 | +4.2% | 0.00% | – |
| Q3 2022 | $83,000 | +6.4% | 1,130 | -5.8% | 0.00% | – |
| Q2 2022 | $78,000 | +34.5% | 1,199 | +12.1% | 0.00% | – |
| Q1 2022 | $58,000 | +18.4% | 1,070 | +14.8% | 0.00% | – |
| Q4 2021 | $49,000 | -54.2% | 932 | -38.2% | 0.00% | – |
| Q3 2021 | $107,000 | +13.8% | 1,508 | +7.0% | 0.00% | – |
| Q2 2021 | $94,000 | -40.5% | 1,410 | -0.6% | 0.00% | – |
| Q1 2021 | $158,000 | -29.8% | 1,418 | -24.7% | 0.00% | -100.0% |
| Q4 2020 | $225,000 | +25.0% | 1,883 | -6.2% | 0.00% | 0.0% |
| Q3 2020 | $180,000 | +1.1% | 2,007 | +1.8% | 0.00% | 0.0% |
| Q2 2020 | $178,000 | -3.8% | 1,972 | +7.7% | 0.00% | 0.0% |
| Q1 2020 | $185,000 | – | 1,831 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |